-37.4%
IONQ vs GSK
+9.5%
-47.0%
-63.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -1.2% | -1.4% | -3.1% |
| 7D | +15.3% | -1.1% | +16.4% | +14.7% |
| 30D | -6.1% | +7.8% | -13.9% | -3.0% |
| 3M | -21.6% | +0.3% | -21.9% | -21.0% |
| 6M | -40.1% | +3.4% | -43.6% | -38.4% |
| YTD | -24.1% | +5.9% | -30.0% | -21.9% |
| 1Y | -37.4% | +8.2% | -45.6% | -35.5% |
| All | -37.4% | +9.5% | -47.0% | -35.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling